Solace Named to The Globe and Mail’s Seventh Annual Ranking of Canada’s Top Growing Companies
OTTAWA, ON, Sept. 30, 2025 /PRNewswire/ -- Solace, the leader in powering real-time,…
Medicenna Announces Results of Annual Meeting of Shareholders
TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or…
2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook.
2025 first-half earnings: RIBER confirms the rollout of its roadmap and its…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma…
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the…
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
September 18, 2025 16:30 ET | Source: NovaBay Pharmaceuticals Inc. EMERYVILLE, Calif.,…
NYSE Content Advisory: Annual International Day Slate Announced
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The New York Stock Exchange…
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association (ATA) Annual Meeting
Highlights Independent institutional experience shows archival cytology slides enabled successful molecular results…
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar”…
